Literature DB >> 10918638

Pharmacological magnetic resonance imaging: a new application for functional MRI.

R A Leslie1, M F James.   

Abstract

Various methods, including functional magnetic resonance imaging (fMRI), have recently been developed to allow investigators to study functional activity in the living brain. Such techniques are now being used to investigate regionally specific brain activity associated with the administration of CNS-active drugs. fMRI in particular is increasingly recognized as being a relatively non-invasive way to perform pharmacological investigations in experimental animals, healthy human volunteers, and individuals with CNS disease. This use of fMRI, dubbed 'pharmacological MRI' or 'phMRI', holds the promise of providing relatively straightforward pharmacodynamic assays and can be used to establish brain-penetrability parameters, or dose-ranging information for novel therapeutic compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918638     DOI: 10.1016/s0165-6147(00)01507-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  36 in total

1.  Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs.

Authors:  B E H Sumner; L A Cruise; D A Slattery; D R Hill; M Shahid; B Henry
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

2.  Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging.

Authors:  Sakthivel Sekar; M Verhoye; J Van Audekerke; G Vanhoutte; Andrew S Lowe; Andrew M Blamire; Thomas Steckler; A Van der Linden; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2010-11-20       Impact factor: 4.530

3.  Quantitative pharmacologic MRI: mapping the cerebral blood volume response to cocaine in dopamine transporter knockout mice.

Authors:  Teodora-Adriana Perles-Barbacaru; Daniel Procissi; Andrey V Demyanenko; F Scott Hall; George R Uhl; Russell E Jacobs
Journal:  Neuroimage       Date:  2010-12-23       Impact factor: 6.556

4.  Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study.

Authors:  Pilar Salgado-Pineda; Pauline Delaveau; Carles Falcon; Olivier Blin
Journal:  Br J Clin Pharmacol       Date:  2006-06-23       Impact factor: 4.335

Review 5.  [Functional magnetic resonance imaging and antipsychotics. Overview and own data].

Authors:  D F Braus; S Brassen
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

6.  Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI.

Authors:  C-L Chin; A E Tovcimak; V P Hradil; T R Seifert; P R Hollingsworth; P Chandran; C Z Zhu; D Gauvin; M Pai; J Wetter; G C Hsieh; P Honore; J M Frost; M J Dart; M D Meyer; B B Yao; B F Cox; G B Fox
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

7.  Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging.

Authors:  Sakthivel Sekar; J Van Audekerke; G Vanhoutte; A S Lowe; A M Blamire; A Van der Linden; T Steckler; M Shoaib; Marleen Verhoye
Journal:  Psychopharmacology (Berl)       Date:  2011-05-07       Impact factor: 4.530

Review 8.  Use of magnetic resonance imaging in pharmacogenomics.

Authors:  Roberto Viviani; Marie-Louise Lehmann; Julia C Stingl
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

9.  Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia.

Authors:  Céline Risterucci; Karine Jeanneau; Stephanie Schöppenthau; Thomas Bielser; Basil Künnecke; Markus von Kienlin; Jean-Luc Moreau
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

10.  Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge.

Authors:  Duncan J Hodkinson; Carmen de Groote; Shane McKie; J F William Deakin; Steve R Williams
Journal:  Br J Med Med Res       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.